News
Novartis raises mid-term sales outlook on pipeline promise
Novartis has raised its guidance for sales growth out to 2029 on the strength of its pipeline and the potential of late-stage R&D assets
News
Eisai debuts biliary tract cancer drug in Japan
Eisai has launched its new therapy for biliary tract cancer (BTC) Tasfygo in Japan, the first world market for the FGFR-targeting drug
News
23andMe stock sell-off adds to its woes
Shares in genetic testing company 23andMe continue to slide after prominent investors announce plans to sell their stakes
Sales & Marketing
Eliminate swivel chair processes to streamline claims manage...
Healthcare professionals (HCPs) rely on biopharma companies for accurate drug information. Out-of-date claims can damage both brand reputation and industry credibility.
Sales & Marketing
Sponsored
Solution Spotlight: Within3
Within3’s disease community analytics provide an understanding of influence within a disease community – not just expertise.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
